BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8040966)

  • 1. From the Centers for Disease Control and Prevention. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    JAMA; 1994 Aug; 272(6):424-5. PubMed ID: 8040966
    [No Abstract]   [Full Text] [Related]  

  • 2. Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jul; 43(28):505-9. PubMed ID: 8022396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006.
    Williams IT; Bell BP; Kuhnert W; Alter MJ
    Arch Intern Med; 2011 Feb; 171(3):242-8. PubMed ID: 21325115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels.
    Rumi MG; Colombo M; Gringeri A; Mannucci PM
    Ann Intern Med; 1990 Mar; 112(5):379-80. PubMed ID: 2106281
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin.
    Jonas MM; Baron MJ; Bresee JS; Schneider LC
    Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C transmission associated with intravenous immunoglobulins.
    Nübling CM; Willkommen H; Löwer J
    Lancet; 1995 May; 345(8958):1174. PubMed ID: 7536875
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis C following administration of intravenous immunoglobulins].
    Cabrera Chaves T; Simón Marco MA; Gomollón García F; Botella Esteban MT; Uribarrena Echebarría R
    Gastroenterol Hepatol; 1996; 19(6):305-8. PubMed ID: 8754418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spurious outbreak of HCV in bone-marrow recipients treated with cytomegalovirus immunoglobulin.
    Ward KN; Morgan G; Ashworth K; Bremner J; O'Callaghan A; Teo CG
    Lancet; 1992 Nov; 340(8830):1290-1. PubMed ID: 1359345
    [No Abstract]   [Full Text] [Related]  

  • 9. The prevalence of hepatitis C virus antibodies among high risk groups in Thailand.
    Poovorawan Y; Pongpunlert W; Chumdermpadetsuk S; Sakulramrung R; Israsena S
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):133-4. PubMed ID: 1658945
    [No Abstract]   [Full Text] [Related]  

  • 10. The peak impact of an Egyptain outbreak of hepatitis C virus: has it passed or has not yet occurred?
    El Sherbini A; Mohsen SA; Hasan W; Mostafa S; El Gohary K; Moneib A; Abaza AH
    Liver Int; 2007 Aug; 27(6):876-7. PubMed ID: 17617132
    [No Abstract]   [Full Text] [Related]  

  • 11. Transmission of hepatitis after the administration of intravenous immunoglobulins.
    Rousell RH; Dobkin MB; Budinger MD; Louie RE
    Am J Clin Pathol; 1993 May; 99(5):649. PubMed ID: 8493958
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus infection and chronic liver disease after bone marrow transplantation--the Taiwan experience.
    Chen PM; Chiou TJ; Liu JH; Fan FS; Hsieh RK; Wei CH; Liu RS; Tzeng CH
    Transplant Proc; 1993 Aug; 25(4 Suppl 3):65-6. PubMed ID: 7688914
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C after intravenous immunoglobulin.
    Sewell WA; Mullighan CG; Christie J; Chapel HM
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):466-7. PubMed ID: 9396984
    [No Abstract]   [Full Text] [Related]  

  • 14. Post transfusion hepatitis: comparison between homologous and autologous blood transfusion.
    Meraviglia P; Viganï P; Gubertini G; Santoli E; Santoli C; Cargnel A
    Eur J Med; 1992 May; 1(2):75-9. PubMed ID: 1342376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody to hepatitis C (anti C 100-3) in French hemophiliacs.
    Maisonneuve P; Laurian Y; Guerois C; Verroust F; Ferrer Le Coeur F; Couroucé AM; Noel L
    Nouv Rev Fr Hematol (1978); 1991; 33(3):263-6. PubMed ID: 1956764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seropositivity to hepatitis C virus in Tunisian haemodialysis patients.
    Jemni S; Ikbel K; Kortas M; Mahjoub J; Ghachem L; Bidet JM; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):349-51. PubMed ID: 7534398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of non-A, non-B hepatitis in the United States.
    Alter MJ; Hadler SC; Francis DP; Maynard JE
    Prog Clin Biol Res; 1985; 182():71-9. PubMed ID: 3929264
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus infection in kidney transplant patients.
    Marcen R; Pascual J; Orofino L; Fernandez Muñoz R; Teruel JL; Celma ML; Liaño F; Ortuño J
    Transplant Proc; 1992 Feb; 24(1):87-8. PubMed ID: 1371628
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C virus antibodies in patients on hemodialysis.
    San Miguel G; Crespo J; Echevarria S; D'Francisco A; Gomez Ullate P; Pons Romero F
    Infect Control Hosp Epidemiol; 1992 May; 13(5):254, 256. PubMed ID: 1375612
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C experience at a community teaching hospital.
    Woodall DW; Godenick M; Valainis GT
    J Fam Pract; 1994 Sep; 39(3):257-61. PubMed ID: 7521389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.